Jaime Vanourny, MD
NPI 1508028093 · Dermatology Physician · Gastonia, NC
Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1508028093
- Entity type
- Individual
- Primary specialty
- Dermatology PhysicianAllopathic & Osteopathic Physicians
- Credential
- MD
- Sex
- Female
- Sole proprietor
- No
- License
- R8536 (IA)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
17 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
3 documented practice locations
- Medicare service volume (vs. specialty peers)25% of score
4,416 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Destruction of Precancer Skin Growth, 2-14 Growths17003 | 1,677 | $6 |
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 922 | $87 |
| Destruction of Precancer Skin Growth, 1 Growth17000 | 561 | $48 |
| Biopsy of Related Skin Growth, First Growth11102 | 376 | $84 |
| Destruction of Skin Growth, 1-14 Growths17110 | 221 | $107 |
| Biopsy of Related Skin Growth, Each Additional Growth |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 31 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Ketoconazole | 160 | 100 |
| Triamcinolone Acetonide | 108 | 76 |
| Valacyclovir Hclbrand: Valacyclovir | 74 | 48 |
| Fluorouracil | 69 | 61 |
| Mupirocin | 65 | 39 |
| Nystatin | 61 | 45 |
| Metronidazole | 53 | 35 |
| Clobetasol Propionate | 50 | 38 |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$5,301 across 139 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Additional practice locations (2)
- 7476 Waterside Loop RdDenver, NC 28037-7679Phone: (704) 601-4381Fax: (704) 822-5997
- 13539 Reese Blvd WHuntersville, NC 28078-7961Phone: (704) 892-4878Fax: (704) 892-7453
Registry dates
- Enumerated
- 2008-06-26
- Last updated
- 2023-08-28
- Certified
- 2023-08-28
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.